Balance Sheet

Assets

+47%

+95%

10Y

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	544	2 950	1 029	2 975	921	2 079	214	162	941	222	198	412	396	785	1 923	8 209	4 358	7 994	17 223	15 369	15 298	21 156	19 202	29 726
Cash	0	0	0	0	0	0	0	0	11	0	0	0	61	20	64	41	65	4	6	1	0	1	0	0
Cash Equivalents	544	2 950	1 029	2 975	921	2 079	214	162	952	222	198	412	335	765	1 859	8 168	4 293	7 990	17 217	15 368	15 298	21 156	19 202	29 726
Short-Term Investments	7	1 010	594	6	528	960	465	396	589	1 048	1 172	984	964	1 118	812	2 022	1 586	180	10	4 991	6 197	7 394	3 758	6 971
Total Receivables	7 381	12 712	17 189	18 739	24 474	31 687	36 901	28 085	36 145	46 293	46 411	45 992	46 731	40 880	38 882	43 671	42 058	35 981	34 817	31 375	32 189	37 569	40 331	39 901
Accounts Receivables	7 379	12 558	17 152	18 536	23 550	30 694	36 053	27 260	34 353	44 119	42 331	41 442	41 178	37 373	35 257	39 219	37 365	31 677	29 120	26 831	26 871	33 466	35 513	34 287
Other Receivables	2	154	37	203	924	993	848	825	1 792	2 174	4 080	4 550	5 553	3 507	3 625	4 452	4 693	4 304	5 697	4 544	5 317	4 103	4 817	5 614
Inventory	4 822	6 841	8 513	11 006	9 740	8 241	7 570	9 147	6 658	6 421	5 568	6 453	7 306	9 367	11 157	12 072	13 048	12 110	12 932	14 808	20 391	30 448	32 890	37 215
Other Current Assets	42	39	78	104	603	663	688	1 168	1 702	2 377	2 237	1 401	1 941	348	608	1 059	97	1 464	1 148	1 943	1 959	6 075	2 304	1 541
Total Current Assets	12 798	23 551	27 402	32 829	36 265	43 629	45 837	38 959	46 034	56 362	55 586	55 242	57 338	52 498	53 383	67 035	61 147	57 730	66 130	68 486	76 033	102 641	98 485	115 354
PP&E Net	9 232	8 112	7 438	6 657	6 163	5 850	6 100	11 287	12 705	14 061	14 650	15 318	17 540	21 913	23 268	25 431	24 017	23 188	30 876	38 570	46 294	46 978	54 313	85 042
PP&E Gross	9 232	8 112	7 438	6 657	6 163	5 850	6 100	11 287	12 705	14 061	14 650	15 318	17 540	21 913	23 268	25 431	24 017	23 188	30 876	38 570	46 294	46 978	54 313	85 042
Accumulated Depreciation	3 555	5 326	6 672	7 619	8 241	8 771	9 135	9 476	7 363	7 591	8 114	8 655	9 401	10 615	12 578	14 925	17 574	20 208	23 343	24 179	26 874	29 513	32 340	34 763
Intangible Assets	191	184	162	324	258	245	178	354	335	373	3 931	3 576	2 878	3 245	2 892	1 747	1 244	755	268	370	424	336	564	1 122
Note Receivable	0	50	6	30	10	0	30 742	41 153	25 430	5 467	5 536	5 141	5 065	5 276	5 626	0	0	0	0	4 213	74	100	74	46
Long-Term Investments	928	708	701	544	836	550	26 715	26 721	26 755	46 189	45 835	46 325	46 282	45 833	45 529	33 878	33 087	24 001	27 858	8 232	20 663	18 371	21 747	18 197
Other Long-Term Assets	187	565	1 962	2 133	1 969	2 166	2 308	638	568	595	1 085	1 187	1 870	1 703	1 934	2 629	2 320	3 063	2 774	13 206	14 155	932	1 745	1 524
Total Assets	23 336 N/A	33 170 +42%	37 673 +14%	42 517 +13%	45 502 +7%	52 441 +15%	111 880 +113%	119 113 +6%	111 827 -6%	123 047 +10%	126 623 +3%	126 789 +0%	130 972 +3%	130 468 0%	132 632 +2%	130 721 -1%	121 816 -7%	108 737 -11%	127 906 +18%	133 077 +4%	157 643 +18%	169 359 +7%	176 927 +4%	221 285 +25%
Liabilities
Accounts Payable	2 277	3 273	3 984	4 006	5 642	5 167	3 849	3 103	3 099	3 457	2 868	3 347	3 659	5 133	4 665	5 810	7 904	6 310	5 402	4 825	8 179	11 633	10 230	12 569
Accrued Liabilities	167	339	511	427	1 621	1 037	1 072	665	1 302	1 561	3 114	1 403	1 721	2 277	2 894	4 130	3 748	3 458	4 879	4 080	5 787	6 608	7 496	8 248
Short-Term Debt	3 541	3 837	3 445	8 205	7 590	10 391	25 489	28 840	17 902	31 499	30 307	37 221	40 817	36 890	28 094	19 907	24 055	21 450	17 137	26 501	15 812	20 523	35 672	39 655
Current Portion of Long-Term Debt	480	433	594	655	570	382	4 310	0	0	2 750	5 620	2 376	1 764	2 023	1 024	2 970	8 230	8 679	11 166	3 231	5 142	13 888	556	531
Other Current Liabilities	849	822	1 221	1 287	4 255	1 008	761	2 194	2 184	2 133	1 776	1 662	5 585	4 050	3 786	5 682	6 232	8 600	11 120	11 520	10 128	5 932	7 803	10 878
Total Current Liabilities	7 314	8 703	9 755	14 579	19 677	17 985	35 481	34 802	24 486	41 401	43 686	46 009	53 546	50 373	40 463	38 499	50 168	48 498	49 703	50 157	45 049	58 584	61 758	71 881
Long-Term Debt	5 604	4 546	6 656	6 001	2 291	5 926	7 245	2 250	6 778	5 350	3 692	8 277	1 452	429	7 742	13 076	12 757	9 827	8 645	9 462	15 966	2 232	369	19 241
Deferred Income Tax	106	66	0	0	0	0	0	2 588	1 714	222	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	383	387	1 167	1 296	1 705	1 808	2 329	2 408	2 531	2 647	5 447	4 372	4 327	5 779	7 225	7 943	7 170	7 331	8 491	16 325	14 164	5 585	5 444	4 725
Total Liabilities	13 406 N/A	13 702 +2%	17 577 +28%	21 876 +24%	23 673 +8%	25 719 +9%	45 055 +75%	42 049 -7%	35 509 -16%	49 620 +40%	52 825 +6%	58 658 +11%	59 325 +1%	56 580 -5%	55 430 -2%	59 518 +7%	70 095 +18%	65 657 -6%	66 840 +2%	75 945 +14%	75 178 -1%	66 400 -12%	67 571 +2%	95 846 +42%
Equity
Common Stock	2 500	3 600	3 600	3 600	3 600	4 300	6 445	6 445	6 714	6 714	6 714	6 714	7 177	7 177	7 177	7 177	7 177	7 177	7 177	7 177	7 177	7 177	7 177	7 177
Retained Earnings	4 593	6 191	6 819	7 364	8 551	9 824	10 061	15 809	16 170	13 553	13 923	8 202	6 217	8 456	11 776	5 773	15 033	14 102	355	9 815	11 725	34 998	45 501	58 886
Additional Paid In Capital	1 300	8 140	8 140	8 140	8 140	11 061	48 782	48 884	50 583	50 583	50 583	50 638	55 676	55 676	55 676	55 676	55 676	55 676	55 676	55 676	55 676	55 676	55 676	55 676
Unrealized Security Profit/Loss	1 537	1 537	1 537	1 537	1 537	1 537	1 537	5 926	5 926	5 652	5 652	5 652	5 652	5 652	5 647	5 651	6 951	2 596	933	5 652	10 962	8 183	4 077	6 774
Treasury Stock	0	0	0	0	0	0	0	0	3 075	3 075	3 075	3 075	3 075	3 075	3 075	3 075	3 075	0	0	0	0	3 075	3 075	3 075
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	24	3 075	3 075	1 559	3 075	0	0	0
Total Equity	9 930 N/A	19 468 +96%	20 096 +3%	20 640 +3%	21 828 +6%	26 721 +22%	66 825 +150%	77 064 +15%	76 318 -1%	73 427 -4%	73 798 +1%	68 132 -8%	71 647 +5%	73 887 +3%	77 202 +4%	71 203 -8%	51 721 -27%	43 080 -17%	61 066 +42%	57 132 -6%	82 465 +44%	102 959 +25%	109 356 +6%	125 439 +15%
Total Liabilities & Equity	23 336 N/A	33 170 +42%	37 673 +14%	42 517 +13%	45 502 +7%	52 441 +15%	111 880 +113%	119 113 +6%	111 827 -6%	123 047 +10%	126 623 +3%	126 789 +0%	130 972 +3%	130 468 0%	132 632 +2%	130 721 -1%	121 816 -7%	108 737 -11%	127 906 +18%	133 077 +4%	157 643 +18%	169 359 +7%	176 927 +4%	221 285 +25%
Shares Outstanding
Common Shares Outstanding	5	7	7	7	7	9	13	13	13	13	13	13	14	14	14	14	14	14	14	14	14	14	14	14

Income Statement Balance Sheet Cash Flow Statement

Daehan New Pharm Co Ltd
KOSDAQ:054670

Balance Sheet

Balance Sheet Decomposition
Daehan New Pharm Co Ltd

Balance Sheet
Daehan New Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Daehan New Pharm Co Ltd KOSDAQ:054670

Balance Sheet

Balance Sheet Decomposition Daehan New Pharm Co Ltd

Balance Sheet Daehan New Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Daehan New Pharm Co Ltd
KOSDAQ:054670

Balance Sheet Decomposition
Daehan New Pharm Co Ltd

Balance Sheet
Daehan New Pharm Co Ltd